Whilst a previous study of vectored malaria vaccines observed a reduction in T-cell immunogenicity in malaria exposed populations compared to UK volunteers [32], IFNγ responses in our volunteers receiving 5×1010 vp ChAd63 ME-TRAP were comparable with Phase Ia data (Table 6) [35]. The gene discussed is IFNG; the disease is malaria.